No annual revenue total was found in TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.'s SEC filings.
Translational Development Acquisition Corp. (TDAC) files with the SEC under industry code 6770, Blank Checks.
Revenue
—
Net income (TTM)
$5.54M
Operating cash flow (TTM)
$-849,378
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
0
Net cash
—
Operating margin
—
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- TDAC (Nasdaq), TDACU (Nasdaq), TDACW (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1926599
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
|---|---|---|
| Operating income | -$944,538 | -$196,358 |
| Net income | $6.4M | -$71,012 |
| Operating cash flow | -$608,387 | -$851,446 |
| Total assets | $181.7M | $175.0M |
| Total liabilities | $6.6M | $6.2M |
| Stockholders' equity | -$6.5M | -$5.6M |
| Cash and investments | $29,787 | $438,174 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 27, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Other events
|
Jul 8, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Other events
|
Jun 23, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Jun 12, 2026 | Jun 12, 2026 |
All 80 Translational Development Acquisition Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.